Demand cancer drugs that truly help patients

Drug regulators and trial designs should assess benefits that actually matter to people with cancer, says Ajay Aggarwal.

Original Source

Publication Date: 
12/04/2018
Ajay Aggarwal
Nature
151
151
Attachment(s): 
drug regulators and trial designs cancer drugs.pdf
Tags:
Cancer, Drugs, Drug Industry, United States Of America (US), Medical Research